Literature DB >> 23374122

Brucella evasion of adaptive immunity.

Anna Martirosyan1, Jean-Pierre Gorvel.   

Abstract

The complex immune system of mammals is the result of evolutionary forces that include battles against pathogens, as sensing and defeating intruders is a prerequisite to host survival. On the other hand, microorganisms have evolved multiple mechanisms to evade both arms of immunity: the innate and the adaptive immune systems. The successful pathogenic intracellular bacterium Brucella is not an exception to the rule: Brucella displays mechanisms that allow evasion of immune surveillance in order to establish persistent infections in mammals. In this review, we highlight some key mechanisms that pathogenic Brucella use to evade the adaptive immune system.

Entities:  

Mesh:

Year:  2013        PMID: 23374122     DOI: 10.2217/fmb.12.140

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  16 in total

1.  Mechanism of Asp24 upregulation in Brucella abortus rough mutant with a disrupted O-antigen export system and effect of Asp24 in bacterial intracellular survival.

Authors:  Mingxing Tian; Jing Qu; Xiangan Han; Chan Ding; Shaohui Wang; Daxin Peng; Shengqing Yu
Journal:  Infect Immun       Date:  2014-04-21       Impact factor: 3.441

2.  Chronic Brucella Infection Induces Selective and Persistent Interferon Gamma-Dependent Alterations of Marginal Zone Macrophages in the Spleen.

Authors:  Arnaud Machelart; Abir Khadrawi; Aurore Demars; Kevin Willemart; Carl De Trez; Jean-Jacques Letesson; Eric Muraille
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

3.  Brucella canis is an intracellular pathogen that induces a lower proinflammatory response than smooth zoonotic counterparts.

Authors:  Carlos Chacón-Díaz; Pamela Altamirano-Silva; Gabriela González-Espinoza; María-Concepción Medina; Alejandro Alfaro-Alarcón; Laura Bouza-Mora; César Jiménez-Rojas; Melissa Wong; Elías Barquero-Calvo; Norman Rojas; Caterina Guzmán-Verri; Edgardo Moreno; Esteban Chaves-Olarte
Journal:  Infect Immun       Date:  2015-10-05       Impact factor: 3.441

Review 4.  Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions.

Authors:  Paul de Figueiredo; Thomas A Ficht; Allison Rice-Ficht; Carlos A Rossetti; L Garry Adams
Journal:  Am J Pathol       Date:  2015-04-17       Impact factor: 4.307

5.  Milk yield and reproductive performance of brucellosis-vaccinated but seropositive Holstein cows.

Authors:  Miguel Mellado; Angel M Garcia; Beatriz Arellano-Reynoso; Efren Diaz-Aparicio; Jose E Garcia
Journal:  Trop Anim Health Prod       Date:  2013-11-20       Impact factor: 1.559

6.  The Brucella effector protein TcpB induces degradation of inflammatory caspases and thereby subverts non-canonical inflammasome activation in macrophages.

Authors:  Padmaja Jakka; Swapna Namani; Subathra Murugan; Nivedita Rai; Girish Radhakrishnan
Journal:  J Biol Chem       Date:  2017-10-23       Impact factor: 5.157

7.  CD8+ T cell exhaustion, suppressed gamma interferon production, and delayed memory response induced by chronic Brucella melitensis infection.

Authors:  Marina Durward-Diioia; Jerome Harms; Mike Khan; Cherisse Hall; Judith A Smith; Gary A Splitter
Journal:  Infect Immun       Date:  2015-09-28       Impact factor: 3.441

Review 8.  The Role of Neutrophils in Brucellosis.

Authors:  Edgardo Moreno; Elías Barquero-Calvo
Journal:  Microbiol Mol Biol Rev       Date:  2020-10-14       Impact factor: 11.056

Review 9.  Establishment of Chronic Infection: Brucella's Stealth Strategy.

Authors:  Waqas Ahmed; Ke Zheng; Zheng-Fei Liu
Journal:  Front Cell Infect Microbiol       Date:  2016-03-15       Impact factor: 5.293

10.  In vivo identification and characterization of CD4⁺ cytotoxic T cells induced by virulent Brucella abortus infection.

Authors:  Anna Martirosyan; Kristine Von Bargen; Vilma Arce Gorvel; Weidong Zhao; Sean Hanniffy; Johnny Bonnardel; Stéphane Méresse; Jean-Pierre Gorvel
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.